Melanotan 2 (MT2) · Research brief

Melatonin Stacking Guide — Advanced Protocols | Real

Real Peptides Research TeamEditorial

Updated March 31, 202611 min read

59 WORDS

Short answer

Peptides Nearly 60% of melatonin users report diminishing results after the first 8–12 weeks of solo supplementation. Not because the compound stops working, but because they've hit the ceiling of what single-agent protocols can achieve. The real research frontier isn't higher doses of isolated melatonin; it's strategic stacking with synergistic compounds that target different phases of the sleep-wake cycle.

Key takeaways

Melatonin is a chronobiotic hormone that signals circadian timing. Not a sedative. Which is why stacking with GABAergic or thermoregulatory compounds produces synergistic effects that melatonin monotherapy cannot achieve.
Clinical trials show that 0.3–1mg melatonin effectively normalizes circadian rhythms, while the 10mg doses sold in most retail stores exceed physiological levels by 10–30 times and risk receptor desensitization over time.
Glycine lowers core body temperature by 0.3–0.5°C and increases slow-wave sleep by 8–12%. Addressing the thermal gate for deep sleep that melatonin alone cannot open.
Sleep onset insomnia requires immediate-release melatonin paired with anxiolytics like L-theanine or magnesium, while sleep maintenance insomnia responds better to extended-release melatonin combined with sustained GABAergic compounds.
Magnesium threonate crosses the blood-brain barrier more efficiently than citrate or oxide forms, making it the preferred choice for neurological sleep applications rather than peripheral muscle relaxation.
Advanced stacking protocols match compound mechanisms to specific sleep phenotypes. Random combinations without targeting circadian misalignment, anxiety-driven arousal, or thermal dysregulation produce inconsistent results.

Melatonin Stacking Guide — Advanced Protocols | Real Peptides

Nearly 60% of melatonin users report diminishing results after the first 8–12 weeks of solo supplementation. Not because the compound stops working, but because they've hit the ceiling of what single-agent protocols can achieve. The real research frontier isn't higher doses of isolated melatonin; it's strategic stacking with synergistic compounds that target different phases of the sleep-wake cycle.

We've spent years analyzing sleep architecture data and peptide interaction profiles. The gap between basic melatonin supplementation and optimized stacking protocols isn't subtle. It shows up in measurable changes to REM latency, slow-wave sleep percentage, and next-day cognitive performance.

What is a melatonin stacking guide?

A melatonin stacking guide is a systematic protocol for combining melatonin with complementary sleep-regulating compounds to enhance circadian rhythm synchronization, improve sleep architecture quality, and address multiple neurochemical pathways simultaneously. Research-grade stacking protocols typically combine 0.3–5mg melatonin with GABA modulators, serotonin precursors, or neuropeptides that target distinct receptor populations. Creating synergistic effects that isolated supplementation cannot achieve.

Most consumers assume melatonin is a sedative. It isn't. Melatonin is a chronobiotic hormone that signals darkness and synchronizes circadian timing. The fatigue you feel 30–90 minutes post-dose isn't direct sedation; it's your suprachiasmatic nucleus interpreting the melatonin signal as nighttime and downregulating wake-promoting orexin neurons. That's why timing matters more than dose, and why stacking with actual GABAergic compounds or adenosine modulators produces measurably different sleep quality outcomes. This melatonin stacking guide covers the neurochemical mechanisms behind effective combinations, evidence-based dosage ranges for each compound class, timing protocols that maximize bioavailability, and the critical mistakes that negate synergistic effects entirely.

Understanding Melatonin's Role in Sleep Architecture and Why Stacking Works

Melatonin binds primarily to MT1 and MT2 receptors in the suprachiasmatic nucleus. The brain's master circadian clock. MT1 activation inhibits wake-promoting neuronal firing, while MT2 activation phase-shifts circadian rhythms toward earlier sleep onset. The half-life of exogenous melatonin ranges from 20–50 minutes depending on formulation and metabolic factors, which means blood levels peak at 30–60 minutes and return to baseline within 3–4 hours. This short duration explains why melatonin excels at sleep initiation but does nothing for sleep maintenance. Unless you're using extended-release formulations or stacking with compounds that address mid-sleep awakenings through different mechanisms.

The key insight that drives melatonin stacking protocols: different neurotransmitter systems regulate different phases of the sleep cycle. Melatonin handles circadian timing and initial sleep pressure. GABA-A receptor agonists (like magnolia bark extract or L-theanine) reduce pre-sleep cortical arousal and anxiety-driven hyperarousal. Glycine enhances inhibitory neurotransmission in the brainstem and spinal cord, lowering core body temperature. A necessary precondition for deep sleep entry. Compounds like Pinealon work through entirely separate pathways, supporting neuroplasticity and cellular recovery during sleep rather than inducing sleep itself. When you combine these, you're not just taking "more sleep stuff". You're orchestrating a multi-receptor protocol that addresses circadian misalignment, anxiety-driven insomnia, thermal dysregulation, and recovery signaling simultaneously.

A 2019 meta-analysis published in Sleep Medicine Reviews found that melatonin monotherapy reduced sleep onset latency by an average of 7.2 minutes. Clinically significant but modest. Combination protocols that added glycine or magnesium threonate showed 18–22 minute reductions with measurably higher slow-wave sleep percentages on polysomnography. The mechanism isn't additive; it's synergistic. Melatonin sets the circadian gate, glycine opens the thermal gate, and GABAergic compounds silence the cortical noise that prevents gate entry. Miss any one component and the entire system underperforms.

Core Melatonin Stacking Compounds: Mechanisms, Dosage Ranges, and Timing Protocols

Every effective melatonin stacking guide starts with understanding the compound categories that produce synergistic effects. Not random combinations pulled from supplement marketing copy. The three primary categories are chronobiotics (melatonin itself), anxiolytics and GABAergic modulators (compounds that reduce neuronal excitability), and thermoregulatory agents (compounds that facilitate the core body temperature drop required for deep sleep). Secondary additions include neuropeptides that support recovery processes during sleep and adaptogens that modulate HPA-axis activity preventing cortisol-driven early awakenings.

Melatonin (0.3–5mg, 60–90 minutes pre-sleep): Start at 0.3–1mg. The dose shown in clinical trials to normalize circadian rhythms without next-day grogginess. The 10mg melatonin tablets sold in most retail stores exceed physiological levels by 10–30 times, which saturates receptors and can paradoxically worsen sleep quality over time through receptor desensitization. Immediate-release melatonin suits people with sleep onset insomnia. Extended-release formulations (releasing 40% immediately, 60% over 6–8 hours) address sleep maintenance issues but require 90–120 minute advance timing. Sublingual formulations bypass first-pass hepatic metabolism, achieving peak plasma levels in 15–20 minutes. Useful for shift workers or travelers managing acute circadian misalignment.

Glycine (3–5g, 60 minutes pre-sleep): Glycine acts as an inhibitory neurotransmitter in the brainstem and spinal cord while also activating NMDA receptors in the suprachiasmatic nucleus, which signals peripheral thermoreceptors to initiate heat dissipation. Lowering core body temperature by 0.3–0.5°C. A 2015 study in Frontiers in Neurology found that 3g glycine before bed increased slow-wave sleep by 8–12% and reduced sleep onset latency by 15 minutes compared to placebo. The mechanism complements melatonin perfectly: melatonin tells the brain it's nighttime, glycine creates the physiological conditions (lower core temp, reduced neuronal excitability) that allow deep sleep to occur.

Magnesium Threonate or Glycinate (200–400mg elemental magnesium, 60–90 minutes pre-sleep): Magnesium acts as a natural NMDA receptor antagonist and GABA-A receptor agonist. Reducing excitatory neurotransmission while enhancing inhibitory tone. Magnesium threonate crosses the blood-brain barrier more effectively than other forms, making it the preferred choice for neurological effects rather than just peripheral muscle relaxation. Typical dosing: 2000mg magnesium threonate (yielding ~140mg elemental magnesium) combined with 200mg magnesium glycinate for a total of 300–350mg elemental magnesium.

L-Theanine (200–400mg, 30–60 minutes pre-sleep): An amino acid found in green tea that increases alpha-wave brain activity (associated with relaxed alertness) while modulating dopamine, serotonin, and GABA levels. L-theanine doesn't sedate. It reduces the anxiety-driven rumination that prevents sleep initiation. Stacking 200mg L-theanine with 0.5–1mg melatonin addresses both circadian timing and pre-sleep cognitive hyperarousal, the two most common causes of sleep onset insomnia in high-stress populations.

For researchers exploring advanced peptide-based recovery protocols during sleep, compounds like Pinealon and DSIP Peptide represent emerging tools that work through distinct neurochemical pathways. Supporting cellular repair and neuroprotection during the sleep cycle rather than inducing sleep through receptor modulation. These belong to a different category than traditional sleep aids and require careful protocol design.

Advanced Melatonin Stacking Protocols: Evidence-Based Combinations for Specific Sleep Phenotypes

The most common mistake in melatonin stacking is combining compounds randomly without matching the protocol to the specific sleep dysfunction. Sleep onset insomnia (difficulty falling asleep) requires different neurochemical intervention than sleep maintenance insomnia (waking at 2–4am unable to return to sleep) or non-restorative sleep (sleeping 7–8 hours but waking unrefreshed). A melatonin stacking guide built for real-world application must differentiate between these phenotypes and recommend stacks that target the underlying mechanisms.

Protocol 1. Sleep Onset Insomnia (Circadian Misalignment + Anxiety): Immediate-release melatonin 0.5–1mg + L-theanine 200mg + magnesium glycinate 200mg, taken 60 minutes before target sleep time. This stack addresses three mechanisms: melatonin shifts circadian phase earlier, L-theanine reduces pre-sleep rumination and cortical arousal, and magnesium enhances GABAergic inhibition. The expected outcome is 15–25 minute reduction in sleep onset latency within 3–5 nights. If ineffective after one week, the issue likely isn't circadian or anxiety-driven. Consider sleep apnea screening or restless leg syndrome evaluation.

Protocol 2. Sleep Maintenance Insomnia (Mid-Sleep Awakenings): Extended-release melatonin 2–3mg + glycine 3–5g + magnesium threonate 2000mg (140mg elemental), taken 90 minutes before bed. The extended-release melatonin provides sustained MT1/MT2 receptor activation for 6–8 hours, glycine maintains the core temperature reduction necessary for deep sleep continuation, and magnesium threonate sustains GABAergic tone throughout the night. This stack reduced mid-sleep awakenings by 40–60% in observational studies tracking sleep fragmentation in shift workers and perimenopausal women.

Protocol 3. Non-Restorative Sleep (Adequate Duration, Poor Architecture): Immediate-release melatonin 0.3mg + glycine 5g + apigenin 50mg (from chamomile extract) + magnesium threonate 2000mg. This protocol prioritizes deep sleep quality over sedation. The low melatonin dose minimizes receptor saturation, glycine and magnesium maximize slow-wave sleep percentage, and apigenin (a flavonoid that binds benzodiazepine receptors without the tolerance and dependence risk) enhances stage 3 NREM sleep. Expected outcome: 10–15% increase in slow-wave sleep percentage measurable via sleep tracking devices or polysomnography.

We've reviewed stacking protocols across hundreds of research applications in this space. The pattern is consistent: protocols that match compound mechanisms to specific sleep dysfunction outperform high-dose melatonin monotherapy by measurable margins. Generic "sleep stacks" marketed without phenotype specificity rarely produce sustained results beyond placebo.

Melatonin Stacking Guide: Comparison of Core Sleep Compounds

Understanding how different compounds work. And which combinations produce synergistic rather than redundant effects. Is essential for building an effective melatonin stacking protocol. The table below compares mechanism of action, optimal dosing, timing, and when each compound is most appropriate.

Compound	Mechanism of Action	Optimal Dose	Timing Before Sleep	Primary Use Case	Synergy with Melatonin	Professional Assessment
Melatonin (immediate-release)	MT1/MT2 receptor agonist; circadian phase-shifter	0.3–1mg	60–90 minutes	Sleep onset insomnia, jet lag, circadian misalignment	N/A (base compound)	Essential for circadian gating. Start here before adding other compounds
Melatonin (extended-release)	Sustained MT1/MT2 activation over 6–8 hours	2–3mg	90–120 minutes	Sleep maintenance insomnia, mid-sleep awakenings	N/A (base compound)	Use only if mid-sleep awakenings are the primary complaint. Not for sleep onset issues
Glycine	NMDA receptor activation in SCN; core temperature reduction	3–5g	60 minutes	Non-restorative sleep, poor slow-wave sleep	High. Addresses thermal gate melatonin cannot	The single most underused compound in consumer sleep protocols. Clinical evidence is robust
Magnesium Threonate	NMDA antagonist, GABA-A agonist, crosses BBB efficiently	2000mg (140mg elemental)	60–90 minutes	Anxiety-driven insomnia, neuronal hyperexcitability	High. Reduces cortical noise preventing melatonin's circadian signal	Prefer threonate over citrate or oxide for neurological effects
L-Theanine	Increases alpha-wave activity, modulates serotonin and GABA	200–400mg	30–60 minutes	Pre-sleep rumination, stress-induced insomnia	Moderate. Addresses cognitive arousal, not circadian timing	Excellent for high-stress populations. No next-day sedation
Apigenin	Benzodiazepine receptor partial agonist (no tolerance risk)	50mg	60 minutes	Poor sleep architecture, low slow-wave sleep percentage	Moderate. Enhances depth, melatonin handles timing	Chamomile-derived flavonoid. Gentler than pharmaceutical GABAergics

What If: Melatonin Stacking Scenarios

What If I've Been Taking 10mg Melatonin Nightly and It Stopped Working?

Reduce to 0.3–1mg immediately and add glycine 3–5g plus magnesium threonate 2000mg to your protocol. High-dose melatonin (above 3mg) saturates MT1 and MT2 receptors, which triggers receptor downregulation over 4–8 weeks. The receptors become less responsive to the melatonin signal, requiring higher doses to achieve the same effect until even 10mg produces minimal results. This isn't tolerance in the addiction sense; it's regulatory adaptation. Dropping to physiological doses (0.3–1mg) allows receptor populations to upregulate again over 2–3 weeks. Adding glycine and magnesium addresses the sleep maintenance and depth issues that high-dose melatonin was masking but not actually fixing. Most people see measurable improvement within 5–7 nights.

What If I Experience Next-Day Grogginess from Melatonin Stacks?

Switch to immediate-release melatonin at 0.3mg (not extended-release) and move your dosing window to 90 minutes before sleep instead of 30–60 minutes. Next-day grogginess typically indicates one of three issues: dose too high, extended-release formulation creating sustained receptor activation past your wake time, or dosing too close to bedtime so peak plasma levels occur during sleep rather than before it. The solution is earlier timing and lower dose. If grogginess persists at 0.3mg dosed 90 minutes pre-sleep, remove melatonin entirely and use a glycine-magnesium-theanine stack without the chronobiotic component. Some individuals are slow melatonin metabolizers (CYP1A2 polymorphisms) and accumulate the compound overnight.

What If I'm Using Melatonin for Shift Work or Jet Lag?

Use immediate-release melatonin 0.5–1mg at your target sleep time in the new time zone (for jet lag) or 90 minutes before your intended sleep period (for shift work), and avoid light exposure for 60 minutes after dosing. Melatonin's phase-shifting effect depends on timing relative to your circadian nadir (the lowest point of your body temperature rhythm, usually 2–4am). Taking melatonin in the late afternoon or early evening shifts your rhythm earlier (useful for eastward travel); taking it in the early morning shifts your rhythm later (useful for westward travel). For shift workers on rotating schedules, pair melatonin with blackout curtains and blue-light-blocking glasses during your designated sleep period. The compound can't override constant light exposure.

What If I Want to Add Peptides to My Sleep Stack?

Compounds like DSIP Peptide and Pinealon work through mechanisms distinct from melatonin, GABA modulation, or thermoregulation. They support cellular repair, neuroprotection, and recovery signaling during sleep rather than inducing sleep onset. These belong in recovery-focused protocols, not sleep-induction stacks. If sleep architecture is already optimized through a melatonin-glycine-magnesium base protocol and your goal shifts to maximizing neuroplasticity or tissue repair during sleep, peptide additions make sense. Start with the foundational sleep stack first; add peptides once baseline sleep quality is consistently high.

The Clinical Truth About Melatonin Stacking

Here's the honest answer: most commercial "sleep stacks" are designed to maximize ingredient count for marketing purposes. Not to target specific neurochemical pathways. A product that combines melatonin, valerian root, passionflower, chamomile, GABA, 5-HTP, L-tryptophan, and magnesium in sub-therapeutic doses of each isn't a sophisticated protocol. It's a liability hedge. The manufacturer can claim "includes clinically studied ingredients" while delivering none of them at effective doses.

The evidence is clear: effective melatonin stacking requires three elements. First, a chronobiotic dose of melatonin (0.3–3mg depending on phenotype) timed to your circadian phase. Second, one or two compounds that address the specific mechanism preventing sleep. GABAergic compounds for anxiety-driven insomnia, glycine for thermal dysregulation, magnesium for neuronal hyperexcitability. Third, consistency. Circadian interventions require 5–7 days to produce measurable phase shifts. Random nightly variations in timing or dose negate the cumulative effect. A simple three-compound stack taken at the same time nightly outperforms a ten-compound product taken sporadically.

The supplement industry has conditioned consumers to believe more ingredients equal better results. In sleep pharmacology, the opposite is true. Every additional compound introduces another variable, another half-life to manage, another potential interaction. The best melatonin stacking guide is the one that tells you what not to take.

Melatonin works. But only within the narrow biological role it evolved to serve. It signals darkness to the suprachiasmatic nucleus, phase-shifts circadian rhythms, and reduces sleep onset latency by 7–15 minutes in people with circadian misalignment. It does not sedate. It does not address anxiety, rumination, restless legs, sleep apnea, or chronic pain. Stacking melatonin with compounds that do address those mechanisms. L-theanine, magnesium, glycine, apigenin. Produces measurably better outcomes than high-dose melatonin monotherapy. But the benefit comes from mechanistic precision, not ingredient volume. If your sleep dysfunction has a circadian component, melatonin belongs in your protocol at 0.3–1mg. If it doesn't, melatonin won't help no matter what you stack it with. And that clarity is worth more than any 15-ingredient proprietary blend.

For research applications requiring the highest purity standards and exact amino-acid sequencing, Real Peptides manufactures every compound through small-batch synthesis with third-party verification. That same commitment to precision applies here: know the mechanism, match the compound, dose it correctly, time it consistently. The rest is noise.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Melatonin stacking improves sleep quality by targeting multiple neurochemical pathways simultaneously — melatonin handles circadian timing through MT1/MT2 receptor activation, while stacked compounds like glycine reduce core body temperature, magnesium enhances GABAergic inhibition, and L-theanine reduces pre-sleep cortical arousal. Clinical studies show combination protocols reduce sleep onset latency by 18–22 minutes compared to 7.2 minutes with melatonin monotherapy, while also increasing slow-wave sleep percentage by 8–15% on polysomnography. The synergy occurs because each compound addresses a different gate in the sleep initiation and maintenance process — melatonin alone only opens the circadian gate.

The optimal melatonin dose for stacking protocols is 0.3–1mg for sleep onset insomnia and 2–3mg extended-release for sleep maintenance insomnia — significantly lower than the 5–10mg doses sold in most retail supplements. Doses above 3mg saturate MT1 and MT2 receptors, triggering receptor downregulation over 4–8 weeks and reducing melatonin’s effectiveness. When stacking with compounds like glycine or magnesium that address different mechanisms, the lower melatonin dose handles circadian signaling while the other compounds manage thermal regulation, GABAergic tone, and anxiety reduction.

Combining melatonin with prescription sleep medications requires prescriber oversight, as interactions depend on the specific drug class — benzodiazepines, Z-drugs (zolpidem, eszopiclone), and sedating antidepressants all have distinct pharmacological profiles that may interact with melatonin or stacked supplements. Melatonin generally poses low interaction risk, but compounds commonly stacked with it (magnesium, L-theanine, apigenin) can potentiate GABAergic effects, increasing sedation or next-day cognitive impairment. Never combine prescription sleep medications with supplement stacks without explicit prescriber approval — the combined effects on respiratory drive, particularly in individuals with sleep apnea, can create safety risks.

Most people notice improved sleep onset latency within 3–5 nights of starting a properly designed melatonin stacking protocol, but measurable improvements in sleep architecture — increased slow-wave sleep percentage, reduced mid-sleep awakenings — typically require 7–14 days of consistent use. Circadian phase shifts induced by melatonin follow a dose-response curve that accumulates over multiple nights, meaning the full chronobiotic effect takes 5–7 days to stabilize. If no improvement occurs after two weeks of consistent timing and dosing, the sleep dysfunction likely has a non-circadian cause requiring different intervention (sleep apnea screening, restless leg evaluation, or psychiatric assessment for primary insomnia).

Glycine and magnesium address different mechanisms, making the choice dependent on your specific sleep phenotype — glycine (3–5g) is more important for individuals with poor sleep architecture or insufficient slow-wave sleep, as it lowers core body temperature and increases deep sleep percentage by 8–12%. Magnesium (200–400mg elemental, preferably as threonate) is more important for individuals with anxiety-driven insomnia or neuronal hyperexcitability, as it acts as an NMDA antagonist and GABA-A agonist. For comprehensive protocols addressing both sleep initiation and maintenance, stacking melatonin with both glycine and magnesium produces synergistic effects that neither compound achieves alone.

Next-day grogginess from melatonin stacks typically results from three factors: dose too high (above 3mg), extended-release formulations creating sustained receptor activation past wake time, or slow melatonin metabolism due to CYP1A2 genetic polymorphisms. The fix is to reduce melatonin to 0.3mg immediate-release, move dosing to 90 minutes before sleep instead of 30–60 minutes, and ensure you’re allowing 7–8 hours between dosing and wake time. If grogginess persists at physiological doses with proper timing, remove melatonin entirely and use a glycine-magnesium-L-theanine stack without the chronobiotic component — some individuals accumulate melatonin overnight regardless of dose.

Properly designed melatonin stacking protocols at physiological doses (0.3–3mg) do not lose effectiveness over time — receptor downregulation only occurs with chronic supraphysiological dosing above 5–10mg nightly. The compounds commonly stacked with melatonin (glycine, magnesium, L-theanine, apigenin) do not produce tolerance or dependence when used at evidence-based doses. If a stack stops working after 8–12 weeks, the issue is typically changing sleep dysfunction (new stressor, shift in circadian demands, onset of sleep apnea) rather than pharmacological tolerance. Cycling off supplements every 8–12 weeks is unnecessary unless doses have crept upward — in which case the correct response is dose reduction, not cessation.

Melatonin stacking can support shift work sleep disorder management, but requires precise timing relative to your target sleep period — use immediate-release melatonin 0.5–1mg 90 minutes before your intended sleep time, combined with blackout curtains and blue-light-blocking glasses to simulate darkness. Adding glycine 3–5g and magnesium 200–300mg can improve sleep quality during daytime sleep periods when circadian drive for wakefulness is high. The critical mistake shift workers make is taking melatonin at inconsistent times across rotating schedules — the chronobiotic effect depends on timing consistency, so each shift rotation requires a new dosing schedule aligned to that shift’s sleep window.

Immediate-release melatonin reaches peak plasma levels in 30–60 minutes and returns to baseline within 3–4 hours, making it ideal for sleep onset insomnia and circadian phase-shifting. Extended-release melatonin releases 40% immediately and 60% over 6–8 hours, maintaining MT1/MT2 receptor activation throughout the night — appropriate for sleep maintenance insomnia and mid-sleep awakenings. In stacking protocols, immediate-release is preferred when combining with compounds like glycine and magnesium that handle sleep maintenance through different mechanisms; extended-release is used only when mid-sleep awakenings persist despite GABAergic and thermoregulatory support.

Melatonin stacking protocols work best with consistent nightly use for at least 7–14 days, as the chronobiotic effects of melatonin accumulate through repeated phase-shifting of the circadian rhythm — sporadic use prevents the sustained phase adjustment needed to correct circadian misalignment. Once sleep quality stabilizes, some individuals can reduce frequency to 4–5 nights per week, but timing must remain consistent (same clock time nightly) to maintain the circadian anchor. ‘As needed’ use is appropriate only for acute circadian disruptions like jet lag or occasional stress-driven insomnia — chronic sleep dysfunction requires sustained protocol adherence.

Older adults (above 55–60 years) produce 50–70% less endogenous melatonin than younger populations due to pineal gland calcification, making supplemental melatonin more beneficial for circadian regulation — but they also clear melatonin more slowly due to reduced hepatic CYP1A2 activity, requiring lower doses (0.3mg vs 1mg). Stacking protocols for older adults should emphasize magnesium threonate for neuroprotection and glycine for temperature regulation, as core body temperature rhythms flatten with age. Younger populations with intact melatonin production benefit more from stacks targeting anxiety-driven insomnia (L-theanine, magnesium) or performance-driven sleep optimization rather than basic circadian correction.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA